Greenleaf Trust Charles River Laboratories International, Inc. Transaction History

Greenleaf Trust

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$194.44 - $217.61 $6,027 - $6,745	31 Added 3.04%	1,051 $205,000
Q2 2023 Aug 09, 2023	BUY	$183.71 - $210.25 $187,384 - $214,455	1,020 New	1,020 $214,000
Q1 2022 Apr 27, 2022	SELL	$255.51 - $362.11 $193,932 - $274,841	-759 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$351.38 - $448.68 $22,488 - $28,715	-64 Reduced 7.78%	759 $286,000
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $27,575 - $33,914	74 Added 9.88%	823 $340,000
Q2 2021 Aug 10, 2021	BUY	$294.17 - $371.65 $8,825 - $11,149	30 Added 4.17%	749 $277,000
Q1 2021 Apr 30, 2021	BUY	$249.67 - $299.48 $179,512 - $215,326	719 New	719 $208,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

Stay updated on Greenleaf Trust with notifications on news.